Expression of apoptosis regulatory proteins p53 and Bcl-2 in skin of patients with chronic renal failure on maintenance haemodialysis

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 6, 2007, Pages 795-801

  El Domyati, M M ^a   Ahmad, H M ^a   Nagy, I ^a   Zahran, A ^a  

^a MINIA UNIVERSITY   (Egypt)

Author keywords

Apoptosis; Bcl 2; Chronicrenal failure; Haemodialysis; p53

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; PEROXIDASE; PROTEIN BCL 2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; BASAL CELL; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; EPIDERMIS; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAINTENANCE THERAPY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN BIOPSY; SKIN DISEASE; SQUAMOUS CELL;

ADULT; APOPTOSIS REGULATORY PROTEINS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RENAL DIALYSIS; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34250628012     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.02090.x     Document Type: Article

References (29)

1. Warnock DG. Chronic renal failure. In: Bennett JC, Plum F, Gill GN et al., eds. Cecil Textbook of Medicine, vol. 1, 2nd edn, Saunders WB Company, Philadelphia, 1996: 556.
2. Pico MR, Lugo-Somolinos A, Sanchez JL, Burgos-Calderion R. Cutaneous abnormalities in patients with chronic renal failure. Int J Dermatol 1992; 31: 860-863.
3. Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995; 25: 413.
4. Morton CA, Lafferty M, Hau C et al. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant 1996; 11: 2031.
5. Deleixhe-Mautin Kerzinski JM, Rorive G, Pierard GE. Quantification of skin color in patients undergoing maintenance hemodialysis. J Am Acad Dermatol 1992; 27: 950.
6. Yosipovitch G, Reis J, Tur E et al. Sweat secretion, stratum corneum hydration, small nerve function and pruritus in patients with advanced chronic renal failure. Br J Dermatol 1995; 133: 561.
7. Feinstein EI. The skin. In: Daugirdas JT, Ing TS eds. Handbook of Dialysis, 2nd edn. Little Brown Company, Boston, 1994: 583.
8. Kerr JFR, Wyllie AH, Currie AR. Apoptosis. A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239.
9. Columbano A. Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 1995; 58: 181.
10. Vaux DL, Cory S, Adams J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440.
11. Williams GT. Programmed cell death: Apoptosis and oncogenesis Cell 1991; 65: 1097-1098.
12. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456.
13. Warner HR, Hodes RJ, Pocinki K. What does cell death have to do with aging? J Am Geriat Soci 1997; 45: 1140.
14. McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR, Albino AP. Abnormalities of p53 expression in cutaneous disorders. Arch Dermatol 1994; 130: 225.
15. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323.
16. Teraki Y, Shiohara T. Apoptosis and the skin. Eur J Dermatol 1999; 9: 413-426.
17. Hockenberry DM, Zutter M, Hickey W, Nahm Korsmeyer SJ. Bcl-2 is topographically restricted in tissues characterized by apoptotic death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
18. Ortiz A, Justo P, Catalan MP et al. Apoptotic cell death in renal injury: The rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord 2002; 2: 181-192.
19. Savil J. Apoptosis and the kidney. J Am Soci Nephrol 1994; 5: 12-21.
20. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229-240.
21. Chandler D, El-Naggar AK, Brisbay S, Redline RW, McDonnel TJ. Apoptosis and expression of the Bcl-2 proto-oncogene in the fetal and adult human kidney: Evidence for the contribution of Bcl-2 expression to renal carcinogenesis. Human Pathol 1994; 25: 789-796.
22. Liang S, Ohtsuki Y, Furihata M et al. Sun-exposure and aging dependent p53 protein accumulation results in growth advantage for tumor cells in carcinogenesis of nonmelanocytic skin cancer. Virchows Arch 1999; 434: 193.
23. Kikuchi A, Nishikawa T. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Arch Dermatol 1997; 133: 829-833.
24. Eguchi K. Apoptosis in autoimmune diseases. Intern Med 2001; 40: 275-284.
25. El-Domyati M, Attia S, Saleh F et al. Expression of p53 in normal sun-exposed and protected skin (type IV-V) in different decades of age. Acta Derm Venereol 2003; 83: 98-104.
26. El-Domyati M, Attia S, Saleh F et al. Effect of topical tretinoin, chemical peeling and dermabrasion on p53 expression in facial skin. Eur J Dermatol 2003; 13: 433.
27. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
28. Penninger JM, Kroemer G. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv Immunol 1998;38: 329-359.
29. Bowen A, Hanks A, Murphy K, Florell S, Grossman D. Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. Am J Dermatopathol 2004; 26: 177-181.